RANI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Rani Therapeutics Holdings Inc (RANI) is not a good buy for a beginner investor with a long-term strategy at this time. The stock shows no significant positive catalysts, weak financial performance, and lacks strong trading signals or favorable sentiment to justify an immediate investment.
The stock exhibits a bullish moving average pattern (SMA_5 > SMA_20 > SMA_200), and the MACD histogram is positive and expanding. However, RSI_6 at 70.437 indicates a neutral zone, and the pre-market price is down by -1.45%. Key support and resistance levels suggest limited upward momentum in the short term.
NULL. No recent news, no significant hedge fund or insider activity, and no congress trading data available.
The company has shown weak financial performance with a significant drop in net income (-20.21% YoY) and EPS (-50.00% YoY). Pre-market price is also down by -1.45%, and there is no recent SwingMax or AI Stock Picker signal.
In Q3 2025, revenue remained at 0 with no growth, net income dropped to -$5.41M (-20.21% YoY), and EPS fell to -0.12 (-50.00% YoY). Gross margin remained at 100%, but this is not indicative of operational success given the lack of revenue.
No data available on analyst ratings or price target changes.
